Method to Treat Skin Conditions with Narcissus Tazetta Bulb Extract
AssigneeNuSkin International, Inc.
InventorDale Kern
Life of this patent
Estimating the term…
Abstract
Methods for the prevention or treatment of disorders and complications of disorders resulting from cell damage caused by an aging-related isoform of NADH oxidase (arNOX) are described. The agent for such inhibition comprises processed various Narcissus tazetta extracts, preferably IBR-DORMIN® Narcissus tazetta bulb extract, both alone and in combination with other inhibition agents, including ubiquinones like coenzyme Q. These agents bind arNOX and inhibit the ability of arNOX to generate reactive oxygen species, thereby decreasing the ability of arNOX to generate reactive oxygen species. Such agents, and their methods of administration, as extremely effective as part of anti-aging treatments.
Claims9
1-45. (canceled)
A method to inhibit the generation of reactive oxygen species by aging-related isoform of NADH oxidase, comprising the step of:
- administering a therapeutically effective amount of a composition comprising at least one of Narcissus tazetta bulb extract, Schisandra chinensis, Lonicera japonica, Fagopyrum cymosum, methylparaben, L-carnosine, propylparaben, ethylparaben, L-ergothioneine, betulinic acid, or Solanum lycopersicum to a patient in need thereof, such that generation of reactive oxygen species by aging-related isoform of NADH oxidase, is inhibited.
A method to inhibit the generation of reactive oxygen species by aging-related isoform of NADH oxidase, comprising the step of:
- administering a therapeutically effective amount of a composition comprising Narcissus tazetta bulb extract to a patient in need thereof, such that generation of reactive oxygen species by aging-related isoform of NADH oxidase, is inhibited.
Dependencies are inferred from the claim text.